Biogen (BIIB) PT Lowered to $275 at Cowen

March 21, 2019 9:20 AM
Cowen analyst Phil Nadeau lowered the price target on Biogen (NASDAQ: BIIB) to $275.00 (from $400.00) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles